Swiss Firm Takes French Biotech Co. Private For €730.1M
Ares Life Sciences said Thursday it will snap up the rest of French allergy pharmaceutical company Stallergenes Greer it doesn't already own in a 730.1 million euro ($832.5 million) deal guided...To view the full article, register now.
Already a subscriber? Click here to view full article